Skip to content

Clinical trials

Leukemia, Myelogenous, Chronic, BCR-ABL Positive trials in Turkey (Türkiye)

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myelogenous, Chronic, BCR-ABL Positive Country / region: Turkey (Türkiye) Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20072
20081
20112
20133
20171
20181
20191
20211
20222
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting5
Active, not recruiting1
No longer available1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals9
Pfizer2
Ankara University1
Ascentage Pharma Group Inc.1
Bristol-Myers Squibb1
Il-Yang Pharm. Co., Ltd.1
Poitiers University Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myelogenous, Chronic, BCR-ABL Positive16
Leukemia3
Myeloproliferative Disorders3
Bone Marrow Diseases2
Leukemia, Myeloid, Chronic-Phase2
Blast Crisis1
Bronchiolitis Obliterans Syndrome1
Gastrointestinal Stromal Tumors1
Hematologic Diseases1
Hematologic Neoplasms1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.